NewAmsterdam Pharma (NAMS) Shares Outstanding (Diluted Average) (2021 - 2023)

NewAmsterdam Pharma has disclosed Shares Outstanding (Diluted Average) across 3 years of filings, most recently posting $1001.8 for Q2 2023.

• Shares Outstanding (Diluted Average) for Q2 2023 came in at $1001.8, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $1001.8 (changed N/A YoY), and the FY2022 annual result was $979.44, down 30.45% from the prior year.
• Shares Outstanding (Diluted Average) came in at $1001.8 for Q2 2023 at NewAmsterdam Pharma, up from $979.44 in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1361.3 in Q4 2021 to a low of $979.44 in Q4 2022.
• The 3-year median for Shares Outstanding (Diluted Average) is $1001.8 (2023), against an average of $1114.2.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 28.05% in 2022, while the deepest fall reached 28.05% in 2022.
• NewAmsterdam Pharma's Shares Outstanding (Diluted Average) stood at $1361.3 in 2021, then slipped by 28.05% to $979.44 in 2022, then advanced by 2.28% to $1001.8 in 2023.
• The last three Shares Outstanding (Diluted Average) figures came in at $1001.8 (Q2 2023), $979.44 (Q4 2022), and $1361.3 (Q4 2021), per Business Quant data.